In the present study, we specifically investigate the role of TFAP2A in TNBC, and found TFAP2A expression is negatively associated with overall survival of TNBC patients; whereas in Luminal B subtype breast cancer, high expression of TFAP2A indicates a favorable outcome. This evidence concerns the gene TFAP2A and breast cancer.